This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Zouboulis, Ch.C., and Keitel, W., 2002, A Historical review of early descriptions of Adamantiades-Behçet’s disease. J. Invest. Dermatol. 119: 201–205.
Mege, J.L., Dilsen, N., Sanguedolce, V., et al., 1993, Overproduction of monocyte derived tumor necrosis factor α interleukin (IL) 6; IL-8 and increased neutrophil superoxide generation in Behçet’s disease: a comparative study with familial Mediterranean fever and healthy subjects. J. Rheumatol. 20: 1544–1549.
Itoh, R., Takenaka, T., Okitsu-Negishi, S., et al., 1994, Interleukin-8 in Behçet’s disease. J. Dermatol. 21: 397–404.
al-Dalaan, A., al-Sedairy, S., al-Balaa, S., et al., 1995, Enhanced interleukin 8 secretion in circulation of patients with Behçet’s disease. J. Rheumatol. 22: 904–907.
Zouboulis, Ch.C., Katsantonis, J., Ketteler, R., et al., 2000, Adamantiades-Behçet’s disease: Interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch. Dermatol. Res. 292: 279–284.
Sahin, S., Lawrence, R., Direskeneli, H., et al., 1996, Monocyte activity in Behçet’s disease. Br. J. Rheumatol. 35: 424–429.
Baggiolini, M., Walz, A., and Kunkel, S.L., 1989, Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84: 1045–1049.
Baggiolini, M., Dewald, B., and Moser, B., 1994, Interleukin-8 and related chemotactic cytokines — CXC and CC chemokines. Adv. Immunol. 55: 97–179.
Baggiolini, M., 1998, Chemokines and leukocyte traffic. Nature 392: 565–568.
Loetscher, P., Moser, B., and Baggiolini, M., 2000, Chemokines and their receptors in lymphocyte traffic and HIV infection. Adv. Immunol. 74: 127–180.
Murphy, P.M., Baggiolini, M., Charo, I.F., et al. 2000, International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol. Rev. 52: 145–176.
Zlotnik, A., and Yoshie, O., 2000, Chemokines: a new classification system and their role in immunity. Immunity 12: 121–127.
Gerard, C., and Rollins, B.J., 2001, Chemokines and disease. Nature Immunol. 2: 108–115.
Clark-Lewis, I., Schumacher, C., Baggiolini, M., et al., 1991, Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. J. Biol. Chem. 266: 23128–23134.
Clark-Lewis, I., Dewald, B., Geiser, T., et al., 1993, Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proc. Natl. Acad. Sci. USA 90: 3574–3577.
Hébert, C.A., Vitangcol, R.V., and Baker, J.B., 1991, Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J. Biol. Chem. 266: 18989–18994.
Baggiolini, M., Dewald, B., and Moser, B., 1997, Human chemokines: An update. Annu. Rev. Immunol. 15: 675–705.
Berger, E.A., Murphy, P.M., and Farber, J.M., 1999, Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17: 657–700.
Arenzana-Seisdedos, F., Virelizier, J.L., Rousset, D., et al. 1996, HIV blocked by chemokine antagonist. Nature 383: 400.
Crump, M.P., Gong, J.H., Loetscher, P., et al., 1997, Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 16: 6996–7007.
Gong, J.-H., Ratkay, L.G., Waterfield, J.D., et al., 1997, An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J. Exp. Med. 186: 131–137.
Plater-Zyberk, C., Hoogewerf, A.J., Proudfoot, A.E.I., et al., 1997, Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice. Immunol. Lett. 57: 117–120.
Horuk, R., and Ng, H.P., 2000, Chemokine receptor antagonists. Med. Res. Rev. 20: 155–168.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this chapter
Cite this chapter
Baggiolini, M. (2004). Chemokines in Behçet’s Disease, a Field to Be Explored as a Potential Basis for Therapy. In: Zouboulis, C.C. (eds) Adamantiades-Behçet’s Disease. Advances in Experimental Medicine and Biology, vol 528. Springer, Boston, MA. https://doi.org/10.1007/0-306-48382-3_48
Download citation
DOI: https://doi.org/10.1007/0-306-48382-3_48
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-47757-7
Online ISBN: 978-0-306-48382-0
eBook Packages: Springer Book Archive